FDA Inspection 788279 — Validus Pharmaceuticals, Inc.

Validus Pharmaceuticals, Inc. — FEI 3006217317

The FDA completed an inspection of Validus Pharmaceuticals, Inc. on Jul 10, 2012 in Parsippany, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jul 10, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Parsippany, NJ (United States)

Additional details

Postmarket Adverse Drug Experience (PADE)

Citations

IDCFRDescription
673021 CFR 314.80(b)Failure to develop written procedures
673221 CFR 314.80(c)(1)(i)Late submission of 15-day report
682321 CFR 314.80(c)Failure by applicant to report ADE
684221 CFR 314.80(j)Failure to maintain records

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.